Omega-3 for dogs: formulation and shelf life

For an omega-3 product for dogs, the oil's name is only the beginning of a specification. A brand needs data on EPA and DHA content, batch quality, dispensing and performance during use. Attractive packaging and an origin statement do not answer these questions.

A sound brief connects the intended serving with packaging and stability testing. Establish it before choosing a supplier so competing offers can be assessed against the same criteria.

Begin with content per serving

“Salmon oil”, “fish oil” and “omega-3” are not interchangeable composition statements. Where a concept is built around EPA and DHA, define their amounts in the raw material and in the intended serving.

As a calculation example only, 1 g of oil containing 18% EPA and 12% DHA supplies 180 mg EPA and 120 mg DHA. This is not a recommended serving for a dog. The target amount requires separate justification considering intended use, diet and safety.

If directions use millilitres, conversion requires density data. If a pump is used, establish the actual mass delivered per actuation. Without these data, even a correct percentage declaration leaves uncertainty about the administered amount.

The specification needs more than EPA and DHA

Raw material qualification should consider fatty acid profile, identity, oxidation parameters and contaminants relevant to the source. A certificate of analysis should relate to a batch and use methods suitable for the matrix.

A study of North American omega-3 products examined oxidation parameters and the influence of formulation on assessment. For developers, a useful distinction is between fatty acid content testing and oxidative status assessment. The study concerned human supplements and cannot establish the prevalence of non-compliance in canine products.

In practice, peroxide and anisidine values may be included, but method suitability and interpretation should be agreed with the laboratory. TOTOX is a calculated index rather than a replacement for understanding its component results. Limits from voluntary industry standards must not be presented as universal statutory feed limits.

Packaging forms part of the stability design

A multidose bottle, pump and unit-dose pack create different conditions of use. Compare protection from light and oxygen, closure integrity, contact with packaging components and dispensing consistency.

Unit doses may limit repeated opening of the same contents, but barrier properties and sealing still require assessment. A larger bottle should be evaluated over a realistic consumption period. Pack size should not be chosen solely for an attractive retail price.

Developing an oil-based animal product? Contact team@foodup.com.pl. FoodUP helps define raw material specifications, compare packaging and plan stability testing.

Test both unopened and in-use product

The stability programme should reflect labelled storage conditions. Alongside unopened-pack testing, plan an in-use assessment involving opening or pump actuation, depletion of contents and duration of use.

For example, two packs containing the same product can be subjected to a defined dispensing schedule, followed by measurement of selected quality parameters at specified intervals. This is a development approach rather than a ready-made protocol for every formulation; conditions must follow the intended directions.

Quality control and testing should connect with the obligations in Regulation (EC) No 183/2005. Accelerated testing can support development but should not be treated uncritically as proof of performance in every real-use scenario.

Classification and labelling must match composition

A single-ingredient product and an oil blend containing additives may need different classifications. Not every oil should automatically be designated complementary compound feed. Assess ingredients, functions and legal status before establishing the label.

For an additive used as an antioxidant, verify authorisation and conditions of use under Regulation (EC) No 1831/2003. Describing it as “natural” does not resolve this requirement.

Composition and benefit statements must comply with Regulation (EC) No 767/2009. Before printing, conduct a feed label review, comparing the label with specifications and test results.

FAQ

Does the oil's name establish its EPA and DHA content?

No. Composition data and a specification for the particular material are required.

Does a pump always deliver an identical serving?

Do not assume so. Verify dispensing with the final product and packaging.

Is raw material testing enough to establish shelf life?

No. Processing, packaging and use conditions affect the finished product and need their own assessment.

Is every omega-3 product complementary compound feed?

No. Classification depends on composition and product characteristics. A single-ingredient product requires separate consideration.

Sources

Regulation (EC) No 183/2005.

Regulation (EC) No 1831/2003.

Regulation (EC) No 767/2009.

Oxidation levels of North American over-the-counter n-3 supplements and the influence of supplement formulation and delivery form on evaluating oxidative safety.